Track topics on Twitter Track topics that are important to you
This study demonstrates that early initiation of treatment with subcutaneous interferon B-1a following a first clinical demyelinating event significantly delays conversion to multiple sclerosis.
Journal of Neurology, Neurosurgery, and Psychiatry
Original Article: Interferon B-1a for Clinically Isolated SyndromesNEXT ARTICLE
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...